NETGEAR NTGR Falls 352 Watching 2366 Support 20260515 Is ResMed RMD Still a Buy After 089 Rally 20260518 Vox Royalty VOXR Reports Strong Q1 2026 Revenue NA EPS Beats Arista ANET Q1 2026 Earnings EPS 087 Beats Estimates Emkay Global Projects Nifty 50 to Reach 29000 by March 2027 Bullish on Discretionary Consumption Industrials Realty AXT Inc Shares Surge Over 6 as Market Awaits Upcoming Business Developments ITC Q4 Results Net Profit Rises 5 to Rs 5113 Crore Board Declares Rs 8 Per Share Dividend Bezos and Mamdani Clash Over Tax Policy Implications for Investors and NYC Real Estate TechnologyDriven Healthcare Transformation Ushering a New Era of Medicine Vincent Bollors Media Influence Sparks Debate Over Democracy at Cannes Film Festival Trump Mobile Investigates Potential Data Exposure Affecting Thousands of Prospective Customers Robert Half RHI Releases Q1 2026 Earnings Transcript Key Insights Market Edges Higher as Healthcare and Tech Rally Offset Communication Weakness LongTerm Potential of AI Stocks A Decade Outlook Vaxcyte Q1 2026 Earnings EPS Misses Estimates Amid PreCommercial Investment Phase PhenixFIN Corporation PFX Q1 2026 Earnings Strong EPS Surprise of 254 Amid Stable Market Conditions Central Garden Pet Company CENTA Q1 2026 Earnings Earnings Beat Driven by Operational Discipline Amid Mixed TopLine Signals MED Q1 2026 Earnings EPS Surpasses Estimates Amid Cost Management Efforts Sonoco Products SON Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Examining Evolv Technologies Potential Among LowPriced Growth Stocks OKLO Q1 2026 Earnings NarrowerthanExpected Loss Highlights Progress in Advanced Nuclear Development LNSR Earnings Overview 20260522 VOYG Q1 2026 Earnings EPS Misses Estimates Stock Rallies LION Q1 2026 Earnings EPS Surge Drives DoubleDigit Stock Rally CPHI Q3 2011 Earnings EPS Falls Short of Consensus Amid Operational Headwinds Faraday Future Intelligent Electric FFAI Q1 2026 Earnings Narrower Loss Surprises but Revenue Remains Absent DFTX Q1 2026 Earnings EPS Miss as ClinicalStage Biotech Reports WiderThanExpected Loss JUNS Q4 2025 Earnings NarrowerThanExpected Loss Reflects Cost Control Efforts Despite No Revenue